an Endocrine Society Thematic Issue
Endocrine Society journals have published research articles and expert commentary on these important new medicines for years. This thematic issue includes a selection of our latest articles, published in our primary research journals since the start of 2024. These papers explore the multifaceted role of GLP-1 receptor agonist drugs in the treatment of obesity, diabetes, and metabolic disorders. Articles were curated based on the number of downloads, Altmetric score, and selection as a Featured article.
Published: April 2025
It can be difficult to keep up to date in the rapidly evolving and expanding world of endocrine science. We curate topical collections of research from across our journals, Endocrine Reviews, Endocrinology, Journal of the Endocrine Society, The Journal of Clinical Endocrinology & Metabolism, and JCEM Case Reports so that you can easily find and read recent, influential articles on the topics that interest you.
Selection in each Thematic Issue is guided by online metrics, including Altmetric Attention Scores, Featured Article designations, and identification of leading authors and key topics. Several times a year, we publish a new Thematic Issue online and work to highlight and promote endocrine science in the press, through email, on social media and across other distribution channels.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
We provide our journal authors with a variety of resources for increasing the discoverability and citation of their published work. Use these tools and tips to broaden the impact of your article.
